Voloridge Investment Management’s Arlo Technologies ARLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-65,737
Closed -$857K 1151
2024
Q2
$857K Sell
65,737
-222,568
-77% -$2.77M ﹤0.01% 1075
2024
Q1
$3.65M Sell
288,305
-52,374
-15% -$523K 0.01% 727
2023
Q4
$3.24M Sell
340,679
-347,544
-50% -$3.17M 0.01% 715
2023
Q3
$7.09M Buy
688,223
+297,864
+76% +$3.16M 0.04% 550
2023
Q2
$4.26M Buy
+390,359
New +$3.17M 0.02% 731
2022
Q3
Sell
-193,531
Closed -$1.21M 1387
2022
Q2
$1.21M Sell
193,531
-144,467
-43% -$1.06M 0.01% 1143
2022
Q1
$3M Buy
+337,998
New +$3.1M 0.02% 821
2021
Q3
Sell
-98,163
Closed -$665K 1630
2021
Q2
$665K Sell
98,163
-48,429
-33% -$316K ﹤0.01% 1365
2021
Q1
$921K Sell
146,592
-88,360
-38% -$692K 0.01% 1044
2020
Q4
$1.83M Buy
234,952
+200,200
+576% +$1.22M 0.02% 774
2020
Q3
$183K Buy
+34,752
New +$167K ﹤0.01% 1198
2019
Q2
Sell
-26,895
Closed -$111K 748
2019
Q1
$111K Buy
+26,895
New +$149K ﹤0.01% 907

Other funds holding ARLO

Voloridge Investment Management's ARLO Position: Q3 2024 in Review

Voloridge Investment Management sold out of Arlo Technologies (ARLO) in Q3 2024, closing a stake of 65,737 shares — an estimated $857K sold.

Voloridge Investment Management first reported a position in ARLO in Q1 2019 and held it in 12 quarters. The position peaked at $7.09M in Q3 2023. 216 funds tracked by Wall St. Rank hold ARLO as of Q3 2024.

  • Voloridge Investment Management reported no remaining Arlo Technologies position as of Q3 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 65,737 Arlo Technologies shares in Q3 2024, an estimated $857K.
  • Voloridge Investment Management first reported a position in Arlo Technologies in Q1 2019 and held it in 12 quarters.
  • Voloridge Investment Management's Arlo Technologies position peaked at $7.09M in Q3 2023.
  • 216 funds tracked by Wall St. Rank held Arlo Technologies as of Q3 2024.

Based on Voloridge Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.